Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04914234Phase 4Recruiting
Phase 4, randomised, double-blind trial in intraoperative bleeding comparing Atenolol 50 mg with Metoprolol 100 mg (2 arms). Primary endpoint: Mean and Standard deviation of Blood loss. Started Dec 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04914234.